Connecting Early Stage Products with Capital & Channel Partners

The Redefining Early Stage Investments (RESI) conference series connects start-ups with early-stage investors and strategic channel partners. RESI maximizes companies’ fundraising efforts to find partners who are a fit for their techn and development stage. RESI is uniquely cross-border and cross-domain, connecting start-ups with 10 categories of global investors across the silos of drugs, devices, diagnostics and digital health. RESI caters to both the earliest stage start-ups, those seeking grants, seed and angel capital, and the early-stage firms who seek series A and B funding. 

To advance successful deals, all major players, including both buyers and sellers, have a seat at the table. RESI attracts incubators, tech transfer offices, universities, hospitals, research labs and their constituents getting on the radar of investors and channel partners. Biotech, medtech, diagnostics, and digital health companies source global investors and strategic partners, create relationships, and pitch to secure funding from Seed to Series B.